Test Price
2,800 AED✅ Home Collection Available
PDHA1 Gene Pyruvate Dehydrogenase E1-Alpha Deficiency Genetic Test in UAE | 2800 AED | DHA-Compliant Molecular Diagnosis
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Interpretation by DHA-Licensed Genetics Consultant.
- Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731.
Test Overview & Methodology
The PDHA1 Gene Pyruvate Dehydrogenase E1-Alpha Deficiency NGS Test is a definitive molecular assay designed to detect pathogenic variants in the PDHA1 gene, the genetic cause of pyruvate dehydrogenase complex deficiency—a severe metabolic disorder affecting the nervous system and energy metabolism. This UAE-based, DHA-compliant analysis uses next-generation sequencing (NGS) to guarantee complete coverage of the gene's coding regions with greater than 99.9% diagnostic sensitivity, delivering life-altering clinical clarity for affected families and guiding precision management. Clinicians across general practice, neurology, and metabolic medicine rely on this test to confirm suspected mitochondrial dysfunction and differentiate PDHA1 deficiency from other causes of lactic acidosis.
| Feature | Our Test (PDHA1 NGS) | Closest Alternative |
|---|---|---|
| Methodology | Full Gene NGS + CNV Analysis | Biochemical Lactate/Pyruvate Ratio |
| Genetic Coverage | 100% Coding Exons + Splice Sites | No genetic data; only metabolic snapshot |
| Turnaround Time | 3–4 Weeks | 1–2 Days (but not confirmatory) |
| Regulatory Compliance | DHA & UAE Federal Laws on Genetic Testing and Data Protection | Standard laboratory accreditation |
| Clinical Utility | Definitive diagnosis, family screening, prognosis | Suggestive but non‑diagnostic |
Physician Insight & Safety Protocols
"The PDHA1 gene encodes a critical subunit of the pyruvate dehydrogenase complex, and pathogenic variants in this X-linked gene can present with a wide spectrum of clinical severity—from neonatal lactic acidosis to adult-onset neurologic deterioration. Interpreting the molecular data requires careful correlation with the patient's metabolic profile and neuroimaging findings. This NGS-based test provides the definitive genetic answer needed to guide family counseling and long-term management."
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Medication Safety Notice
Do not discontinue any prescribed medication, especially anti‑epileptics or metabolic supplements, without prior physician approval. Abrupt changes can trigger severe metabolic crises in patients with pyruvate dehydrogenase deficiency. Always consult your managing clinician before altering treatment regimens.
Safety Exclusion Criteria & Emergency Red Flags
- Active acute illness with hemodynamic instability – postpone collection until clinical stability is confirmed.
- Test cannot be performed on neonates less than 34 weeks corrected age without NICU clearance.
- Genetic testing of asymptomatic minors requires prior ethics committee approval in accordance with UAE health regulations.
- If the patient experiences sudden severe lethargy, intractable seizures, or respiratory distress, seek immediate emergency medical attention regardless of test status.
Patient FAQ & Clinical Guidance
1. What does the PDHA1 NGS test detect and how accurate is it?
This test identifies single nucleotide variants, small insertions/deletions, and copy number changes across the entire PDHA1 gene with greater than 99.9% analytical sensitivity, making it the most comprehensive diagnostic tool for pyruvate dehydrogenase E1-alpha deficiency. Results provide definitive molecular confirmation essential for clinical management and family counseling.
2. What sample types are accepted and is home collection available?
We accept whole blood, extracted DNA, or a single drop of blood on an FTA card. Our VIP Mobile Phlebotomy team provides hospital‑grade home collection across all emirates with ISO‑certified cold‑chain transport, ensuring sample integrity from doorstep to laboratory. Service is available daily from 8 AM to 11 PM.
3. How long does it take to receive results and what support is provided afterward?
Results are ready within 3–4 weeks and include a detailed molecular report. Every patient receives a complimentary telephonic post‑test consultation with a DHA‑licensed genetics professional to explain findings and guide next steps in management or family testing.
4. Who should consider this genetic test?
This test is indicated for individuals with clinical suspicion of pyruvate dehydrogenase deficiency, including infants with unexplained lactic acidosis, children with developmental delay and hypotonia, and adults with episodic neurologic symptoms suggestive of a mitochondrial disorder. It is also recommended for family members of confirmed cases for carrier testing and early intervention.
5. Is genetic counseling provided with the test?
Yes, genetic counseling is an integral part of the testing process. Our DHA-licensed Consultant Medical Genetics provides pre-test counseling to discuss the implications of testing and post-test counseling to explain results, discuss inheritance patterns, and coordinate family screening when appropriate.
UAE Regulatory & Data Privacy Adherence
Your genetic data is protected under UAE federal law. All testing and data handling comply with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, storage, and processing of personal and genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating digital health records and telemedicine practices.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring patient safety and clinical accountability throughout the testing pathway.
DNA Labs UAE is fully licensed by the Dubai Health Authority (DHA) and adheres to the highest standards of confidentiality and data security.
Clinical & Logistical Metadata
| Test Name | PDHA1 Gene Pyruvate Dehydrogenase E1-Alpha Deficiency NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood, extracted DNA, or FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Analysis |
| ICD-10-CM Code | E74.4 |
| LOINC Code | 83107-8 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians